Eric Venker – Biography
Last update: April 16, 2026Executive profile
Eric was Chief Executive Officer for Talking Meds. Eric Venker joined Sumitomo Chemical in 2017. Eric served as Analyst and Chief of Staff to the CEO for Sumitomo Chemical.
Eric Venker is currentlyChief Executive Officer and Director at Immunovant - View - Immunovant org chart
President and Chief Operating Officer at Roivant Sciences - View - Roivant Sciences org chart
Director at Priovant Therapeutics - View - Priovant Therapeutics org chart
Create your alert
to follow the career of Eric Venker.
Education
Eric Venker has a Doctor of Pharmacy from St. Louis College of Pharmacy and a Doctor of Medicine from Yale University - School of Medicine.
More about Eric Venker
Do you need to know more about Eric Venker? More results.
Participate
Social media
- Eric Venker on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Eric Venker
The colleagues of Eric Venker
Company Colleagues
- At Immunovant, Eric Venker has 30 colleagues including Frank Torti (Chairman of the Board), Douglas Hughes (Director)…
- At Roivant Sciences, Eric Venker has 202 colleagues including Matthew Gline (CEO), James Momtazee (Director)…
- At Priovant Therapeutics, Eric Venker has 49 colleagues including Benjamin Zimmer (CEO), Irena Melnikova (Director)…
Industry Colleagues
- In the Biotechnology industry, Eric Venker has 35,899 colleagues in 2,414 companies located in 43 countries. 17,017 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Eric Venker.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Eric Venker.
